SNDA heads into its May 11 earnings call with a sharp split: the stock up nearly 10% on the week, short interest more than doubled in a month, and the company's largest shareholder adding aggressively.
The dominant story in the ownership register is Conversant Capital. The activist fund bought roughly 3.7 million shares on March 11 at $26.74, spending close to $100 million across multiple tranches. It now controls about 31% of the company. That anchor position gives the stock structural support — and helps explain the 19% one-month rally to $37.80. Against that backdrop, Sonida also published a letter to shareholders on April 28 in connection with its 2026 annual meeting, filing a DEFA14A with the SEC. The Conversant stake is clearly central to how governance conversations at this company now unfold.
Short interest, however, is moving sharply in the other direction. Shorts on SNDA have grown 71% over the past week and are up 147% over the past month, reaching roughly 4.4% of the free float. That pace of increase is hard to ignore. The jump is concentrated: share volume held short leapt from roughly 455,000 to 765,000 between April 22 and April 24 in a single session. Whether that reflects fresh directional bets against the rally, or hedging activity from institutions around the Conversant position, the signal is unambiguous — more traders are paying to be on the other side of this move. The cost to borrow, notably, has dropped to 0.25% after hovering closer to 0.65% through most of April. That collapse in borrow cost is unusual alongside rising short interest; it suggests borrow availability has loosened rather than tightened, with the availability ratio running at a very comfortable 2,906% of short interest — meaning the lending pool is far from stressed. The ORTEX short score of 32 is modest and has barely moved this week, reinforcing the reading that this is not a crowded, high-conviction short position.
On the Street, analysts are arriving late but arriving bullish. Cantor Fitzgerald initiated coverage on April 13 at Overweight with a $36 target. RBC Capital initiated on March 27 at Outperform, targeting $39 — the highest formal target on the name. Baird, covering since January, raised its target from $35 to $37 on April 24 while holding at Neutral. Morgan Stanley, which started coverage in late 2024, raised its target to $31 on April 7. The consensus price target of $35.75 now trails the stock at $37.80 — the stock has outrun analyst targets as new coverage has been initiated. The EV/EBITDA multiple is running at 8.2x, down slightly on a 30-day view, while price-to-book has climbed 37% over the month to 2.35x, reflecting the re-rating in the share price. The days-to-cover rank is in the 75th percentile of the universe, an elevated reading for a stock whose DTC is only 1.36 days on official data — reflecting the small float rather than any particular squeeze risk.
The institutional picture beyond Conversant is thin but notable at the margins. CEO Brandon Ribar sold 7,010 shares on April 3 at $32.18, a modest transaction worth $226,000. The CFO and Chief Accounting Officer made similarly small sales on the same date. Those April sales follow a cluster of executive disposals in early March at $36.64 — ironically closer to where the stock trades today. Neither tranche is large enough in dollar terms to read as a negative conviction signal, and the net 90-day insider balance remains overwhelmingly positive at over $100 million, almost entirely from the Conversant purchases.
LFST, the closest correlated peer by ORTEX data, gained 13% on the week. Direct senior-living peer BKD fell 5% over the same period — a meaningful divergence that underscores how much of SNDA's move is specific to the Conversant situation rather than sector-wide tailwinds. The options market remains almost entirely call-side; the put/call ratio is 0.10, barely above zero, against a 20-day average of 0.06. There is no meaningful defensive hedging visible in the options market right now.
The May 11 earnings print is the next focal point. The last two quarterly reports each produced negative one-day stock reactions — down 9.6% on March 11 and down 0.6% on March 17 — and the five-day drift after the March 11 print was an additional 3.3% lower. The stock now trades well above where it was after either of those reactions, which frames a situation where the rally has priced in a meaningful improvement in the operating story. The Q1 release will test whether occupancy trends and portfolio economics justify the multiple expansion that Conversant's entry and analyst initiations have collectively driven into the stock.
See the live data behind this article on ORTEX.
Open SNDA on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
